Brainstorm Cell Therapeutics, Inc.

NASDAQ: BCLI
Share price (5/13/24): $0.55
Market cap (5/13/24): $37.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Dagher Ibrahim B.

News Filter

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Financial Statements or Exhibits

Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn

Regains Compliance With NASDAQ Minimum Market Value Rule

Announces Agreement With FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC